Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β- amyloid toxicity

T. Kihara, S. Shimohama*, M. Urushitani, H. Sawada, J. Kimura, T. Kume, T. Maeda, A. Akaike

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

192 Scopus citations

Abstract

We examined the effects of nicotinic receptor agonists against beta amyloid (Aβ) cytotoxicity to rat cortical neurons. Administration of nicotine protected against Aβ-induced neuronal death. This neuroprotection was blocked by dihydro-beta-erythroidine, an α4β2 nicotinic receptor antagonist. Furthermore, incubation with cytisine, a selective α4β2 nicotinic receptor agonist, inhibited Aβ cytotoxicity. These results suggest that α4β2 nicotinic receptor activation plays an important role in neuroprotection against Aβ cytotoxicity.

Original languageEnglish
Pages (from-to)331-334
Number of pages4
JournalBrain Research
Volume792
Issue number2
DOIs
StatePublished - 1998/05/11

Keywords

  • Alzheimer's disease
  • Cortex
  • Nicotine
  • α4β2
  • β-amyloid

ASJC Scopus subject areas

  • General Neuroscience
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Fingerprint

Dive into the research topics of 'Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β- amyloid toxicity'. Together they form a unique fingerprint.

Cite this